Isolation and identification of cucurbitane-type triterpenoids with partial agonist/antagonist potential for estrogen receptors from Momordica charantia

scientific article published on 11 April 2011

Isolation and identification of cucurbitane-type triterpenoids with partial agonist/antagonist potential for estrogen receptors from Momordica charantia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/JF200418G
P698PubMed publication ID21456596

P2093author name stringYueh-Hsiung Kuo
Chin Hsu
Ching-jang Huang
Chin-Lin Hsieh
P2860cites workMedicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese MomordicaQ33934615
Cucurbitane triterpenoids from Momordica charantia and their cytoprotective activity in tert-butyl hydroperoxide-induced hepatotoxicity of HepG2 cellsQ42783631
Octanorcucurbitane triterpenoids protect against tert-butyl hydroperoxide-induced hepatotoxicity from the stems of Momordica charantia.Q43179304
Momordica charantia constituents and antidiabetic screening of the isolated major compounds.Q54231332
Cucurbitane triterpenoids from Momordica charantiaQ80152759
Structures of New Cucurbitane-Type Triterpenes and Glycosides, Karavilagenins D and E, and Karavilosides VI, VII, VIII, IX, X, and XI, from the Fruit of Momordica charantiaQ104950509
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectestrogenQ277954
Momordica charantiaQ428750
P1104number of pages9
P304page(s)4553-4561
P577publication date2011-04-11
P1433published inJournal of Agricultural and Food ChemistryQ1024905
P1476titleIsolation and identification of cucurbitane-type triterpenoids with partial agonist/antagonist potential for estrogen receptors from Momordica charantia
P478volume59

Reverse relations

cites work (P2860)
Q28486994Activation of AMPK by bitter melon triterpenoids involves CaMKKβ
Q35231058Anti-inflammatory effect of Momordica charantia in sepsis mice
Q38822006Artepillin C and Other Herbal PAK1-blockers: Effects on Hair Cell Proliferation and Related PAK1-dependent Biological Function in Cell Culture.
Q46799064Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.
Q28817944Bitter melon: a panacea for inflammation and cancer
Q34691591Effect of wild bitter gourd treatment on inflammatory responses in BALB/c mice with sepsis
Q38907047Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy
Q36752298Role of GLP-1 in the Hypoglycemic Effects of Wild Bitter Gourd
Q42128185The anti-adiposity effect of bitter melon seed oil is solely attributed to its fatty acid components.
Q45803559The effect of Momordica charantia intake on the estrogen receptors ESRα/ESRβ gene levels and apoptosis on uterine tissue in ovariectomy rats.
Q36494764Unifying mechanisms of action of the anticancer activities of triterpenoids and synthetic analogs
Q38779824Wild Bitter Melon Leaf Extract Inhibits Porphyromonas gingivalis-Induced Inflammation: Identification of Active Compounds through Bioassay-Guided Isolation.